Michael Austwick - Feb 1, 2024 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-Fact for Michael Austwick
Stock symbol
VRNA
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 06:07 AM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Share Options (Right to Buy) Award $0 +144K $0.00 144K Feb 1, 2024 Ordinary Shares 144K $2.29 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 The option vests and becomes exercisable as to one-third of the underlying options on February 1, 2025 and the remainder in eight equal quarterly installments thereafter.